Search - tctmd.com

Displaying 181 - 200 of 1242

Sort: Relevancy | Date

Presentation NY Valves 2024

EXPLORE MRace: Early Feasibility eXperience of Posterior Leaflet restOration to REduce Mitral Regurgitation Using the MRace (Polares)

Presenter: Fabio S. Brito Jr.

June 05, 2024

Presentation NY Valves 2024

Quality of Life After Mitral Valve Transcatheter Edge-to-Edge Repair According to Baseline Tricuspid Regurgitation Severity

Presenter: Collin Brooks

June 05, 2024

Presentation NY Valves 2024

Secondary Mitral Regurgitation: Challenges and Limitations of Current Technology

Presenter: Gorav Ailawadi

June 05, 2024

Presentation NY Valves 2024

Impact of Anatomical Feasibility Following Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation

Presenter: Thomas Elie Modine

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Presentation NY Valves 2024

Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the Eurosmr Registry

Presenter: Thomas Stocker

June 05, 2024

Presentation NY Valves 2024

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Presenter: Bharat Ravishankar

June 05, 2024

Presentation NY Valves 2024

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Presenter: Akshay Desai

June 05, 2024

Presentation NY Valves 2024

Atrial FMR: The Structuralist Perspective – Transcatheter Therapies

Presenter: John Thomas Saxon

June 05, 2024

Presentation NY Valves 2024

Atrial FMR: A Surgeon's Perspective

Presenter: Kendra J. Grubb

June 05, 2024

Presentation NY Valves 2024

Defining Atrial Functional Mitral Regurgitation: Pathophysiology and Imaging Features

Presenter: Paul A. Grayburn

June 05, 2024

Presentation NY Valves 2024

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Presenter: Paul A. Grayburn

June 05, 2024

Presentation NY Valves 2024

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Presenter: Melissa Yen Yen Moey

June 05, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Advertisement

EXPLORE MRace: Early Feasibility eXperience of Posterior Leaflet restOration to REduce Mitral Regurgitation Using the MRace (Polares)

Quality of Life After Mitral Valve Transcatheter Edge-to-Edge Repair According to Baseline Tricuspid Regurgitation Severity

Secondary Mitral Regurgitation: Challenges and Limitations of Current Technology

Impact of Anatomical Feasibility Following Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the Eurosmr Registry

An Automated Echocardiogram Screening Program to Optimize Treatment of Mitral Regurgitation: A Single Center Experience

Atrial FMR: The Heart Failure Perspective – Epidemiology and Medical Management

Atrial FMR: The Structuralist Perspective – Transcatheter Therapies

Atrial FMR: A Surgeon's Perspective

Defining Atrial Functional Mitral Regurgitation: Pathophysiology and Imaging Features

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

TCTMD’s Top 10 Most Popular Stories for March 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content